Additionally, we stated in the CY 2026 OPPS/ASC proposed rule that we believe that the pass-through payment category C1765 may also appropriately describe the Axoguard HA+ Nerve Protector TM because the device, as described by the applicant, is designed to be placed on and around neural structures to be a protective interface between a nerve and the surrounding tissue, to minimize the potential for soft tissue attachments, and to ensure the nerve's ability to glide through tissue structures during anatomic movement, and therefore may be appropriately described as an adhesion barrier consistent with devices described by C1765
Potential Benefits in Research Tissue Repair & Regeneration: BPC-157 has shown the ability to stimulate fibroblast activity and collagen production, supporting healing of tendons, muscles, ligaments, and other connective tissues
Researchers should follow safety recommendations to minimize injection site reactions [7]
Dosing Guidelines and Cycle Length Dosing BPC-157 requires balancing efficacy with conservative safety practices
Together, these two peptides may deliver enhanced tissue repair results
Proponents claim it promotes healing of various tissues, including vascular and nerve tissue, potentially benefiting erectile function
